Quest Diagnostics Inc. earnings per share and revenue
On Feb 10, 2026, DGX reported earnings of 2.42 USD per share (EPS) for Q4 25, beating the estimate of 2.38 USD, resulting in a 1.51% surprise. Revenue reached 2.81 billion, compared to an expected 2.78 billion, with a 0.90% difference. The market reacted with a +7.37% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 13 analysts forecast an EPS of 2.39 USD, with revenue projected to reach 2.85 billion USD, implying an decrease of -1.24% EPS, and increase of 1.73% in Revenue from the last quarter.
FAQ
What were Quest Diagnostics Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Quest Diagnostics Inc. reported EPS of $2.42, beating estimates by 1.51%, and revenue of $2.81B, 0.9% above expectations.
How did the market react to Quest Diagnostics Inc.'s Q4 2025 earnings?
The stock price moved up 7.37%, changed from $191.25 before the earnings release to $205.35 the day after.
When is Quest Diagnostics Inc. expected to report next?
The next earning report is scheduled for Apr 20, 2026.
What are the forecasts for Quest Diagnostics Inc.'s next earnings report?
Based on 13
analysts, Quest Diagnostics Inc. is expected to report EPS of $2.39 and revenue of $2.85B for Q1 2026.